Is cefdinir safe to use in a 26-week pregnant woman with no known allergies or underlying medical conditions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefdinir Safety in Pregnancy at 26 Weeks

Cefdinir is safe to use at 26 weeks of pregnancy, as it is classified as FDA Pregnancy Category B and cephalosporins are considered first-line antibiotics during pregnancy with extensive safety data supporting their use in the second and third trimesters. 1, 2

FDA Classification and Safety Profile

  • Cefdinir was not teratogenic in animal studies at doses up to 70 times the human dose in rats and 0.7 times the human dose in rabbits, with no adverse effects on offspring survival, development, behavior, or reproductive function. 1

  • The FDA label explicitly states that "there are, however, no adequate and well-controlled studies in pregnant women," but recommends use "during pregnancy only if clearly needed," which is standard language for Category B medications. 1

  • At 26 weeks gestation (second trimester), the critical period of organogenesis has passed, making the theoretical risk of congenital malformations minimal. 2, 3

Guideline Support for Cephalosporin Use

  • Cephalosporins are recommended as first-line antibiotics during pregnancy, with priority given to more commonly used agents like cefdinir. 2

  • Multiple guidelines support beta-lactam antibiotics (including cephalosporins) as safe throughout pregnancy, with dose adjustments as needed. 3

  • The European Respiratory Society guidelines note that cephalosporins have been used for many years without documentation of adverse effects on the fetus. 4

Clinical Evidence

  • A retrospective study of 78 pregnant women treated with cefuroxime axetil (another cephalosporin) showed no abnormalities in physical or mental development in 80 infants followed for 18 months, supporting the safety class effect of cephalosporins. 5

  • Cefdinir has demonstrated good efficacy and tolerability in treating respiratory tract and skin infections, with diarrhea being the most common adverse event (not pregnancy-specific). 6

Practical Considerations

  • No dose adjustment is necessary at 26 weeks gestation unless the patient has markedly compromised renal function. 1

  • Cefdinir can be taken with iron-fortified infant formula without significant pharmacokinetic interactions, though iron supplements should be separated by at least 2 hours. 1

  • The medication may cause reddish stools due to interaction with iron in the gastrointestinal tract, which is benign and should not cause alarm. 1

Important Caveats

  • While cefdinir is safe, the underlying infection requiring treatment must be appropriately diagnosed, as untreated maternal infections pose greater risks to both mother and fetus than the antibiotic itself. 2, 3

  • Penicillins remain the absolute first-line choice during pregnancy when appropriate for the infection, with cephalosporins serving as excellent alternatives when penicillin allergy exists or broader coverage is needed. 2

  • The benefit-risk assessment at 26 weeks strongly favors treatment, as the risks of untreated infection (preterm labor, premature membrane rupture, complications to the newborn) far outweigh the minimal theoretical risks of cefdinir exposure. 2

References

Research

Treating common problems of the nose and throat in pregnancy: what is safe?

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2008

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.